Tian-Yi Zhang

Nantong University, Nantong, Jiangsu Sheng, China

Are you Tian-Yi Zhang?

Claim your profile

Publications (7)0 Total impact

  • Article: [Association of chronic hydrocephalus after aneurysmal subarachnoid hemorrhage with transforming growth factor-β1 levels and other risk factors].
    [show abstract] [hide abstract]
    ABSTRACT: To study the role of transforming growth factor-β1 (TGF-β1) levels and other risk factors in the occurrence of chronic hydrocephalus after aneurysmal subarachnoid hemorrhage (aSAH). Patients treated for aSAH in our hospital between January, 2007 and June, 2012 were divided into non-hydrocephalus group and hydrocephalus group. TGF-β1 levels in the cerebrospinal fluid (CSF) were compared between the two groups at different time points. A retrospective analysis was conducted to identify the potential risk factors for chronic hydrocephalus, which were subsequently confirmed by Logistic regression analysis. Of the 129 patients enrolled, 16 (12.4%) developed chronic hydrocephalic with an average diagnosis time of 31.6∓17.0 days. In patients with chronic hydrocephalus, TGF-β1 level in the CSF increased significantly on the 13th day following aSAH (P<0.05). Retrospective analysis showed that the patients with hydrocephalus and those without had significant differences in history of hypertension, times of SAH, Hunt-Hess classification, ventricular expansion, aneurysm position, Fisher classification, ventricular hemorrhage score and intracranial infections (P<0.05). Logistic regression analysis identified ventricular expansion, aneurysm position, Fisher classification, ventricular hemorrhage score and postoperative intracranial infections as significant risk factors for the occurrence of chronic hydrocephalus (P<0.05). In adult patients with aSAH, the risk factors for chronic hydrocephalus include ventricular expansion, aneurysm position, Fisher classification, ventricular hemorrhage score and postoperative intracranial infections. These risk factors can have greater clinical value than TGF-β1 levels in the CSF in predicting the occurrence of chronic hydrocephalus following aSAH.
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University 03/2013; 33(3):382-5.
  • Article: [CT angiography-based simulation of the surgical approach in early operation for ruptured aneurysm].
    [show abstract] [hide abstract]
    ABSTRACT: To simulate the surgical approaches for intracranial aneurysms using three-dimensional CT angiography (3D-CTA) and assess the value of 3D-CTA in early microneurosurgery for ruptured intracranial aneurysms. Forty-eight patients with spontaneous subarachnoid hemorrhage due to ruptured intracranial aneurysm were confirmed by early operation. All the patients were classified according to Hunt-Hess, including 11 of grade I, 29 of grade II, and 8 of grade III. CTA was performed before the operation and surgical simulation was conducted. The preoperative findings on CTA and the intraoperative findings were compared and the clinical value of cerebral 3D-CTA was analyzed. Pre-operative 3D-CTA clearly displayed the location, size and shape of the aneurysms, the axis direction of the aneurysm apex and the width of aneurysm neck. The spatial relation between the parent aneutysm artery, the aneurysm, the peripheral vessels and the bony structures were also demonstrated. These findings were basically consistent with the intraoperative findings. The Glasgow outcome score was 5 in 41 patients, 4 in 4 patients, 3 in 2 patients, and 2 in 1 patient upon discharge from the hospital. Preoperative 3D-CTA examination can simulate the surgery for ruptured aneurysms to help improve the surgical success rate.
    Nan fang yi ke da xue xue bao = Journal of Southern Medical University 12/2009; 29(12):2492-4, 2496.
  • Article: [The photological function of MPA coated CdTe QDs and their biocompatibility].
    [show abstract] [hide abstract]
    ABSTRACT: To investigate the CdTe quantum dots coated with MPA and explore its biocompatibility with living cells. CdTe quantum dots coated with MPA were prepared in aqueous phase and MPA CdTe QDs were Characterized with TEM, fluorospectrophotometer and ultraviolet spectrophotometer. QDs were Modified with with avidin, purified and prepared as fluorescent probe. LSCM was used to observe the expression of MHCII antigen on PMphi cells, which was labeled by QDs. Cell culture and MTT assays were used to determine the biocompatibility of MPA coated CdTe quantum dots with the B-16 cells as target cells. The particle diameter of CdTe quantum dots prepared in aqueous phase was well distributed. They had good photological performance and greater stability after coated with MPA. MHCII antigen on PMphi was labeled with the QDs-Avidin fluorescent probe showed great fluorescence intensity, which was easy to be detected by fluorescence microscope and LSCM. MPA CdTe QDs showed cytotoxicity when its density was very high, but they showed little cytotoxicity during the normal use of influence label density limit. MPA CdTe QDs can be used as new fluorescent label as they are of even size, not easy to bleach or quench, have good photological performance and stability and good biocompatibility.
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 10/2009; 25(10):875-8.
  • Article: [Effects of heat shock protein gp96 on function of macrophages from mouse].
    [show abstract] [hide abstract]
    ABSTRACT: Heat shock protein gp96 (HSPgp96) plays an important role in antigen presenting and specific antitumor immunotherapy, but its effects on macrophages need further investigation. This study was to investigate the effects of HSPgp96 derived from H22 tumor cells on mouse peritoneal elicited macrophages (PEMphi) by detecting some factors that are related to the function of the macrophages. After macrophages were stimulated by HSPgp96, dynamic changes of intracellular free calcium (Ca2+), nitric oxide (NO) and reactive oxygen species (ROS) in the macrophages were measured by the laser scanning confocal microscopy (LSCM) with sensitive fluorescent dye Fluo-3/AM, DAF-FM-DA, and H2DCF-DA. The color immunofluorescence assay was used to observe the expression intensity and distribution of MHC II and CD86 in the macrophages. The production of Ca2+, NO and ROS increased rapidly in the macrophages after stimulation of HSPgp96. Their concentration peaks appeared at 30 s, 80 s, and 580 s after stimulation with the increase scopes of (161.06+/-70.99)%, (77.58+/-31.17)%, and (647.28+/-185.70)%, respectively. The positive rates of MHC II and CD86 were significantly higher in 60 mg/L HSPgp96-stimulated macrophages than in control macrophages [(61.8+/-5.1)% vs. (40.9+/-3.5)%, P<0.01; (54.9+/-2.0)% vs.(23.1+/-3.1)%, P<0.01]. The in vitro stimulation of HSPgp96 may enhance the production of Ca2+, NO and ROS in mouse PEMphi, and up-regulate the expression of MHC II and CD86.
    Ai zheng = Aizheng = Chinese journal of cancer 03/2006; 25(2):153-8.
  • Article: [Endoscopic surgery for hypertensive cerebral hemorrhage].
    [show abstract] [hide abstract]
    ABSTRACT: To evaluate the use of endoscopic surgery for hypertensive cerebral hemorrhage. Sixteen patients with hyertensive intracerebral hematoma were evacuated with neuroendoscope. The surgical invasive markers, volume of remaining hematoma, and prognosis were compared with those of 19 comparable patients undergoing conventional craniotomy. Complete evacuation of hematoma was achieved in 9 patients, and partial evacuation in 7. All patients were followed up for 6 months. According to GOS, the result was excellent in 6 patients, good in 6, fare in 2, poor and dead in one respectively. The volume of remaining hematoa and invasive markers significantly decreased (P < 0.05); No difference was found in prognosis between the two groups (P > 0.05). Neuroendoscopic surgery for hypertensive intracerebral hematoma is characterized by mini-invasion, time-saving, and direct-vision, and is a new approach in this field.
    Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences 08/2005; 30(4):424-6.
  • Article: [Induction of anti-tumor immunity by HSP gp96-peptide complexes].
    [show abstract] [hide abstract]
    ABSTRACT: To immunize the mice with gp96-peptide complexes extracted and purified from different kinds of malignant tumor cells and to observe anti-tumor immunity induced by the complexes. HSP gp96-peptide complexes were extracted and purified from different kinds of malignant tumor cells. Mice were immunized subcutaneously with the complexes from different sources at different doses. Then the mice were challenged with 2 x 10(5) tumor cells on the seventh day after the last immunization. Tumor incidence, weight and histology were observed and compared with those of control group. At the meantime, cytotoxicity activity and nitric oxide production of mouse peritoneal macrophages were detected in vitro after being stimulated with gp96-peptide complexes. The SDS-PAGE and Western blot showed that gp96-peptide complexes were purified successfully. The anti-tumor immunity was correlated with the dose of the complex and the immunized mice could resist the challenge of homogeneous tumor cells. NO secreted from the peritoneal macrophages stimulated with the complex was significantly higher than that of control group and the tumoricidal activity of the macrophages in vitro was markedly promoted by the complex. Mice immunized with appropriate dose of gp96-peptide complexes from H22 tumor cells can resist the challenge of syngeneic tumor cells. NO secreted by macrophages stimulated with the complex might play a key role in the anti-tumor immunity.
    Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology 02/2005; 21(1):17-20.
  • Article: [Expression of PTEN, Cx43, and VEGF in hepatocellular carcinoma].
    Tian-Yi Zhang, Jun-Ling An, Jun-Yi Gu, Song He
    [show abstract] [hide abstract]
    ABSTRACT: Previous studies showed that expression of phosphatase and tensin homology deleted on chromosome ten (PTEN), gap junction protein connexin 43 (Cx43) and vascular endothelial growth factor (VEGF) may play an important role in tumor occurrence and progression. This study was designed to investigate the relationship among the protein expression of PTEN, Cx43, and VEGF in carcinogenesis and progression of hepatocellular carcinoma. The expression of PTEN, Cx43 and VEGF were determined in 47 cases of HCC by streptavidin peroxidase immunohistochemistry. In the hepatocellular carcinoma, the total positive rates of PTEN, Cx43 and VEGF were 76.4%, 42.6%, and 70.2%, respectively. With progression of tumor course, PTEN and Cx43 positive rates decreased (P< 0.05), but the VEGF positive rate significantly increased (P=0.001). In comparison with the group of intrahepatic vascular embolism, PTEN positive rate increased apparently in the group without intrahepatic vascular embolism (P=0.006). Cx43 positive rate was lower in the group with cirrhosis background than that in the group without cirrhosis background (Chi(2)=4.713 5, P=0.03). No significant difference of PTEN positive rate was observed in tumor size, differentiation degree in cancerous tissue and cirrhosis background, Cx43 positive rate in tumor size, differentiation degree in cancerous tissue and intrahepatic vascular embolism, VEGF positive rate in tumor size, differentiation degree in cancerous tissue, cirrhosis background and intrahepatic vascular embolism. Correlation analysis revealed that PTEN positive rate was positively correlated with Cx43 positive rate (Cramer's V=0.394 9, P=0.023), negatively correlated with VEGF positive rate (Cramer's V=0.393 7,P=0.024), but no significant association was observed between Cx43 positive rate and VEGF positive rate (Cramer's V=0.307 2, P=0.064). The aberrant expression of PTEN, Cx43, and VEGF may play a role in occurrence, progression, and intrahepatic metastasis of the hepatocellular carcinoma. Determining the expression of PTEN, Cx43, and VEGF may contribute to synthetically evaluating the biological behavior of hepatocellular carcinoma.
    Ai zheng = Aizheng = Chinese journal of cancer 06/2004; 23(6):662-6.